Menopausal hormone therapy: a better and safer future

@article{Davey2018MenopausalHT,
  title={Menopausal hormone therapy: a better and safer future},
  author={D. Davey},
  journal={Climacteric},
  year={2018},
  volume={21},
  pages={454 - 461}
}
  • D. Davey
  • Published 2018
  • Medicine
  • Climacteric
Abstract Major advances in menopause hormone therapy (MHT) hold promise in the future of better and safer care for women at and after the menopause. The principal advances are: (1) the critical window or ‘window of opportunity’ in the 10 years or so after the menopause, during which the benefits of MHT in healthy women exceed any risks; (2) use of transdermal instead of oral administration of estrogen to reduce the risk of venous thromboembolism; (c) investigation of the use of oral micronized… Expand
Interactions between estradiol, diabetes, and brain aging and the risk for cognitive impairment

References

SHOWING 1-10 OF 71 REFERENCES
Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol.
The impact of micronized progesterone on the endometrium: a systematic review
Progesterone – promoter or inhibitor of breast cancer
  • H. Kuhl, H. Schneider
  • Medicine
  • Climacteric : the journal of the International Menopause Society
  • 2013
Hormone therapy for preventing cardiovascular disease in post-menopausal women.
Postmenopausal hormone therapy: new questions and the case for new clinical trials
...
1
2
3
4
5
...